英文名稱 |
中文名稱 |
CAS號 |
操作 |
(2S)-2-amino-3-(2-chlorophenyl)propanamide |
氯吡格雷雜質(zhì) |
2381221-17-4 |
詳細(xì)
|
Clopidogrel EP Impurity E |
氯吡格雷雜質(zhì)E |
90055-68-8 |
詳細(xì)
|
6'-DesMethyl-6'-carboxy Etoricoxib |
依托考昔雜質(zhì)L |
349536-39-6 |
詳細(xì)
|
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
依地昔布EP雜質(zhì)D |
1810761-43-3 |
詳細(xì)
|
6'-DesMethyl-6'-Methylhydroxy Etoricoxib |
依托考昔雜質(zhì)K |
349536-41-0 |
詳細(xì)
|
BetaMethasone 9,11-Epoxide 17,21-Dipropionate |
環(huán)氧倍他米松-17,21-雙丙酸鹽 |
66917-44-0 |
詳細(xì)
|
Clobetasone butyrate EP Impurity H |
丁酸氯倍他松EP雜質(zhì)H |
25122-56-9 |
詳細(xì)
|
Propionic acid (9R,10S,11S,13S,16S,17R)-9-bromo-11-hydroxy-17-(2-hydroxy-acetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester |
倍氯米松雜質(zhì) |
52092-13-4 |
詳細(xì)
|
BetaMethasone 9,11-Epoxide 17-Propionate |
丙酸倍氯米松EP雜質(zhì)U |
79578-39-5 |
詳細(xì)
|
(11β,16β)-9-BroMo-11-hydroxy-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione |
倍氯米松雜質(zhì)D |
52092-14-5 |
詳細(xì)
|
Etoricoxib Impurity 11 |
依托考昔去甲基雜質(zhì) |
202409-31-2 |
詳細(xì)
|
Thieno[3,2-c]pyridinium, 5-[(2-chlorophenyl)methyl]-6,7-dihydro-, bromide (1:1) |
氯吡格雷雜質(zhì) |
2418591-13-4 |
詳細(xì)
|
Etoricoxib Impurity 13 |
依托考昔雜質(zhì)13 |
1817735-82-2 |
詳細(xì)
|
Benzeneacetic acid, α-amino-2-chloro-, ethyl ester, hydrochloride (1:1), (αS)- |
氯吡格雷雜質(zhì) |
2649375-64-2 |
詳細(xì)
|
Etoricoxib Impurity 10 |
依托考昔雜質(zhì)10 |
316149-01-6 |
詳細(xì)
|
Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, ethyl ester |
氯吡格雷雜質(zhì) |
90055-81-5 |
詳細(xì)
|
Etoricoxib Impurity 8 |
依托考昔雜質(zhì) 8 |
1421227-97-5 |
詳細(xì)
|
Methyl2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetatehydrochloride |
氯吡咯雷雜質(zhì)B |
144750-52-7 |
詳細(xì)
|
Beclomethasone |
倍氯米松(糠酸莫米松雜質(zhì)) |
4419-39-0 |
詳細(xì)
|
Pregna-1,4-diene-3,20-dione, 11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11β,16β)- |
倍氯米松雜質(zhì) |
71934-47-9 |
詳細(xì)
|
Clopidogrel Impurity O |
氯吡格雷雜質(zhì)O |
1332612-57-3 |
詳細(xì)
|
Clopidogrel |
氯吡格雷 |
1314028-89-1 |
詳細(xì)
|
Ticlopidine Impurity 2(Ticlopidine EP Impurity B) |
噻氯匹定雜質(zhì)B(氯吡格雷雜質(zhì)) |
68559-60-4 |
詳細(xì)
|
rac-Clopidogrel Carboxylic Acid |
氯吡格雷雜質(zhì)A |
90055-55-3 |
詳細(xì)
|
Prasugrel |
普拉格雷雜質(zhì)(氯吡格雷雜質(zhì)) |
201049-78-7 |
詳細(xì)
|
Clopidogrel Impurity 25 |
氯吡格雷雜質(zhì)25 |
141109-18-4 |
詳細(xì)
|
Clopidogrel Impurity C |
氯吡格雷N-甲基雜質(zhì) |
1346605-15-9 |
詳細(xì)
|
Clopidogrel bisulfate impurity P |
硫酸氫氯吡格雷雜質(zhì)P |
2418591-12-3 |
詳細(xì)
|
METHYL AMINO(3-CHLOROPHENYL)ACETATE HYDROCHLORIDE |
甲基氨基(3-氯苯基)乙酸鹽酸鹽(氯吡格雷雜質(zhì)) |
1351586-91-8 |
詳細(xì)
|
Clopidogrel Impurity 28 |
氯吡格雷雜質(zhì)28 |
40412-09-7 |
詳細(xì)
|
Ticlopidine EP Impurity E Bromide |
氯吡格雷雜質(zhì)PCR0625 帶溴鹽 |
73099-88-4 |
詳細(xì)
|
2-CHLORO-N-METHYL-N-(4-NITROPHENYL)ACETAMIDE |
2-氯-N-甲基-N-(4-硝基苯基)乙酰胺(尼達(dá)尼布雜質(zhì)) |
2653-16-9 |
詳細(xì)
|
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide |
尼達(dá)尼布雜質(zhì) |
855860-75-2 |
詳細(xì)
|
Nintedanib impurity E |
尼達(dá)尼布雜質(zhì)E |
262366-32-5 |
詳細(xì)
|
2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID |
2-氧代吲哚啉-6-羧酸(尼達(dá)尼布雜質(zhì)) |
334952-09-9 |
詳細(xì)
|
BIBF 1202 |
尼達(dá)尼布雜質(zhì)BIBF 1202 |
894783-71-2 |
詳細(xì)
|
Vildagliptin Impurity 2 |
維格列汀雜質(zhì)2 |
214398-99-9 |
詳細(xì)
|
vildagliptin Impurity J |
維格列汀雜質(zhì)J |
207557-35-5 |
詳細(xì)
|
Vildagliptin Impurity 25 |
維格列汀雜質(zhì)25 |
1563006-28-9 |
詳細(xì)
|
vildagliptin Impurity R |
維格列汀雜質(zhì)R |
1803168-09-3 |
詳細(xì)
|
Nidanib Impurity 7 |
尼達(dá)尼布雜質(zhì)7 |
262368-25-2 |
詳細(xì)
|
Nintedanib Impurity 30 |
尼達(dá)尼布雜質(zhì)30 |
1038972-16-5 |
詳細(xì)
|
Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)- |
尼達(dá)尼布雜質(zhì) |
1860012-61-8 |
詳細(xì)
|
Vildagliptin Impurity 42 |
維達(dá)列汀雜質(zhì)42 |
204387-53-1 |
詳細(xì)
|
4-Amino-N-methylaniline |
N-甲基對苯二胺(尼達(dá)尼布雜質(zhì)) |
623-09-6 |
詳細(xì)
|
N-ACETYLOXINDOLE 97 |
N-乙酰基吲哚酮(尼達(dá)尼布雜質(zhì)) |
21905-78-2 |
詳細(xì)
|
vildagliptin Impurity Q |
維格列汀雜質(zhì)Q |
1803168-08-2 |
詳細(xì)
|
Vildagliptin Chloroacetyl Nitrile (R)-Isomer |
維格列汀氯乙酰丁腈(R)-異構(gòu)體 |
565452-98-4 |
詳細(xì)
|
Vildagliptin Related Compound F |
維格列汀雜質(zhì)F |
1789703-36-1 |
詳細(xì)
|
(R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide |
R-1-氯乙?;?2-氰基吡咯烷(維格列汀雜質(zhì)) |
1211679-98-9 |
詳細(xì)
|
Vildagliptin Related Compound H |
維格列汀雜質(zhì)H |
2253194-13-5 |
詳細(xì)
|
Acetamide, 2,2,2-trichloro-N-methyl-N-(4-nitrophenyl)- |
尼達(dá)尼布雜質(zhì) |
126434-07-9 |
詳細(xì)
|
1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)- |
尼達(dá)尼布雜質(zhì) |
1987887-93-3 |
詳細(xì)
|
N-(4-Nitrophenyl)-2,2,2-trichloroacetamide |
尼達(dá)尼布雜質(zhì) |
4306-32-5 |
詳細(xì)
|
Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)- |
尼達(dá)尼布雜質(zhì)2 |
2653-15-8 |
詳細(xì)
|
Nintedanib Impurity 52 |
尼達(dá)尼布雜質(zhì)52 |
2410284-89-6 |
詳細(xì)
|
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide |
尼達(dá)尼布雜質(zhì)12 |
1139453-98-7 |
詳細(xì)
|
1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester |
尼達(dá)尼布雜質(zhì) |
1277571-69-3 |
詳細(xì)
|
1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl- |
N-(4-氨基苯基)-N-甲基-2-(哌嗪-1-基)乙酰胺(尼達(dá)尼布雜質(zhì)) |
2243384-71-4 |
詳細(xì)
|
3-Amino-4-(carboxymethyl)benzoic acid |
3-氨基-4-(羧甲基)苯甲酸(尼達(dá)尼布雜質(zhì)) |
1373232-85-9 |
詳細(xì)
|
Clopidogrel EP IMpurity D |
氯吡格雷雜質(zhì)D |
1421283-60-4 |
詳細(xì)
|
Clopidogrel EP Impurity F |
氯吡格雷EP雜質(zhì)F |
141109-20-8 |
詳細(xì)
|
Clopidogrel Impurity 3 |
氯吡格雷雜質(zhì)3 |
53885-64-6 |
詳細(xì)
|
(S) - 2 - (2-chlorophenyl) - 2 - ((2 - (thiophene-2-yl) ethyl) amino) methyl acetate hydrochloride |
硫酸氫氯吡格雷雜質(zhì)F |
141109-19-5 |
詳細(xì)
|
1-(2-chlorophenyl)-2-ethoxyethanamine |
氯吡格雷雜質(zhì) |
1485619-90-6 |
詳細(xì)
|
Clopidogrel EP Impurity F (R-Isomer) |
氯吡格雷EP雜質(zhì)F (R-異構(gòu)體) |
1258938-54-3 |
詳細(xì)
|
Clopidogrel Impurity 52 |
氯吡格雷雜質(zhì)52 |
1147350-75-1 |
詳細(xì)
|
Clopidogrel EP I |
氯吡格雷雜質(zhì)I |
144750-42-5 |
詳細(xì)
|
Clopidogrel Impurity 22 |
氯吡格雷雜質(zhì)22 |
138228-61-2 |
詳細(xì)
|
Methyl 2-(2-chlorophenyl)-2-oxoacetate |
(2-氯苯基)氧代乙酸甲酯(氯吡格雷雜質(zhì)) |
34966-49-9 |
詳細(xì)
|
Clopidogrel IMpurity 2 (Clopidogrel IMiniuM IMpurity) |
氯吡格雷溴化吡啶雜質(zhì) |
1396607-49-0 |
詳細(xì)
|
(S)-2-(2-Chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)aceticacid(ClopidogrelImpurity) |
(S)-2-(2-氯苯基)-2-((2-(噻吩-2-基)乙基)氨基)乙酸(氯吡格雷雜質(zhì)) |
1015247-87-6 |
詳細(xì)
|
H-D-PHG-OME HCL |
D-苯甘氨酸甲酯鹽酸鹽(氯吡格雷雜質(zhì)) |
19883-41-1 |
詳細(xì)
|
D-ProlinaMide |
D-脯氨酰胺(維格列汀雜質(zhì)) |
62937-45-5 |
詳細(xì)
|
Vildagliptin IMpurity 2 (Mixture of DiastereoMers) |
維達(dá)列汀雜質(zhì)2(非對映體混合物) |
1036959-23-5 |
詳細(xì)
|
(S)-1-N-CBZ-2-CYANO-PYRROLIDINE |
(S)-1-N-芐氧羰基-2-氰基吡咯烷(維格列汀雜質(zhì)) |
63808-36-6 |
詳細(xì)
|
1-(4-CHLOROPHENYL)-2-METHOXY-2-OXO-1-ETHANAMINIUM CHLORIDE |
RS-4-氯苯甘氨酸甲酯鹽酸鹽(氯吡格雷雜質(zhì)) |
42718-19-4 |
詳細(xì)
|
Vildagliptin Carboxylic Acid Methyl Ester |
維達(dá)列汀羧酸甲酯 |
948574-56-9 |
詳細(xì)
|
Vildagliptin iMpurity K |
維格列汀雜質(zhì) K |
565453-39-6 |
詳細(xì)
|
Vildagliptin Impurity 13 |
維達(dá)列汀雜質(zhì)13 |
2577-48-2 |
詳細(xì)
|
vildagliptin Impurity U |
維格列汀雜質(zhì)U |
38074-72-5 |
詳細(xì)
|
vildagliptin Impurity E |
維格列汀雜質(zhì)E |
1789703-37-2 |
詳細(xì)
|
Vildagliptin Impurity ZA6 |
維格列汀雜質(zhì)ZA6 |
2246354-69-6 |
詳細(xì)
|
Vildagliptin Impurity 18 |
維格列汀雜質(zhì)18 |
23500-10-9 |
詳細(xì)
|
vildagliptin Impurity V |
維格列汀雜質(zhì)V |
1032564-18-3 |
詳細(xì)
|
Vildagliptin Related Compound A |
維格列汀雜質(zhì)A |
741657-02-3 |
詳細(xì)
|
Vildagliptin Carboxylic Acid |
維格列汀羧酸 |
565453-40-9 |
詳細(xì)
|
vildagliptin Impurity Isomer |
維格列汀對映異構(gòu)體 |
1036959-27-9 |
詳細(xì)
|
Vildagliptin Impurity 53 |
維格列汀雜質(zhì)53 |
700376-84-7 |
詳細(xì)
|
Vildagliptin Impurity 57 |
維格列汀雜質(zhì)57 |
913980-23-1 |
詳細(xì)
|
Beclomethasone Dipropionate Impurity |
倍氯米松二丙酸酯雜質(zhì) |
52092-12-3 |
詳細(xì)
|
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-bromo-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11β,16β)- (9CI) |
丙酸倍氯米松雜質(zhì)9 |
52092-15-6 |
詳細(xì)
|
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
依托考昔 N-氧化物 |
325855-74-1 |
詳細(xì)
|
Etoricoxib Impurity 47 |
依托考昔雜質(zhì)45 |
2241145-66-2 |
詳細(xì)
|
Etoricoxib Impurity 18 |
依托考昔雜質(zhì)18 |
1027162-35-1 |
詳細(xì)
|
Etoricoxib Impurity O |
依托考昔雜質(zhì)O |
307531-95-9 |
詳細(xì)
|
2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine |
依托考昔雜質(zhì)P |
307531-96-0 |
詳細(xì)
|
Etoricoxib Impurity 36 |
依托考昔雜質(zhì)36 |
1798110-01-6 |
詳細(xì)
|
Etoricoxib Impurity 9 |
依托考昔雜質(zhì)9 |
859824-65-0 |
詳細(xì)
|
Nintedanib-013-CO |
尼達(dá)尼布標(biāo)準(zhǔn)品-CO |
2218446-42-3 |
詳細(xì)
|
N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE |
2-氯-N-(4-硝基苯基)乙酰胺(尼達(dá)尼布雜質(zhì)) |
17329-87-2 |
詳細(xì)
|